Clinical Trial Update: A Phase II Study of Anlotinib in MTC Patients [Phase 2]

View source ↗

Summary

Phase II study of anlotinib in tumor patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Tumor | Phase 2 | Status: COMPLETED